AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pediatric Hematopoietic Stem Cell Transplantation

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NCT07685457NA1 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome NCT06128070Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Chest Computed Tomography, Echocardiography, Hematopoietic Cell Transplantation, Methotrexate Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA NCT05855083Phase 216 sites๐Ÿ“ San Diego๐Ÿ“ Gainesville๐Ÿ“ Boston Omeros Corporation ยท Tests: Biological: narsoplimab Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation NCT06247501Phase 21 site๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: SNUH-CD19-CAR-T Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection Massage Impact on Sleep in Pediatric Oncology NCT06892158NA2 sites๐Ÿ“ Washington D.C.๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Massage therapy, Standard of care A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients NCT06861257n/a10 sites๐Ÿ“ Bologna๐Ÿ“ Brescia๐Ÿ“ Genova Fondazione IRCCS Policlinico San Matteo di Pavia A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients NCT05711667Phase 333 sites๐Ÿ“ Birmingham๐Ÿ“ Oakland๐Ÿ“ San Francisco Children's Oncology Group ยท Tests: Biospecimen Collection, Letermovir Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT NCT04959903Phase 1, Phase 21 site๐Ÿ“ New York Smart Immune SAS ยท Tests: Allogeneic T cell progenitors, cultured ex-vivo Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation NCT07436650NA1 site๐Ÿ“ Cairo Ain Shams University ยท Tests: high power laser therapy, Basic oral care Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL NCT06559345Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: TMLI, TBI, Cyclophosphamide Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation NCT06916195n/a5 sites๐Ÿ“ Genova๐Ÿ“ Monza๐Ÿ“ Padova MSD Italia S.r.l. Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease NCT07252050Phase 1, Phase 24 sites๐Ÿ“ Aurora๐Ÿ“ Atlanta๐Ÿ“ New Orleans Arkansas Children's Hospital Research Institute ยท Tests: Ruxolitinib Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease NCT06941389n/a37 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Wilmington University of Rochester Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors NCT07662018n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Gemcitabine (GEM), Docetaxel, Melphalan, Carboplatin Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies NCT05011422Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT NCT07387367Phase 381 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ Palo Alto SymBio Pharmaceuticals ยท Tests: cidofovir, Brincidofovir Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation NCT07573111Phase 11 site๐Ÿ“ Palo Alto Laguna Biotherapeutics, Inc. ยท Tests: QUAIL-100 Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease NCT06824103Phase 422 sites๐Ÿ“ Hefei๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Novartis Pharmaceuticals ยท Tests: Ruxolitinib A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS). NCT05090345n/a3 sites๐Ÿ“ Rochester๐Ÿ“ Durham๐Ÿ“ Houston Duke University ยท Tests: Biorepository Trial TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients NCT04098445n/a9 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Boston Children's Hospital Medical Center, Cincinnati Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease NCT06325280n/a1 site๐Ÿ“ Edmonton University of Alberta ยท Tests: Exercise cardiac MRI Assessment, Cardiopulmonary Exercise Test Autologous Stem Cell Transplantation for Crohn's Disease NCT00692939Phase 1, Phase 22 sites๐Ÿ“ Pittsburgh๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG, Melphalan, Thiotepa The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients NCT07718204NA1 site๐Ÿ“ Columbus Nationwide Children's Hospital ยท Tests: MedMemos CD45RA-depleted CD19-CAR T Cell Consolidation After TCRฮฑฮฒ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma NCT07257419Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Anti-Thymocyte Globulin (Rabbit), Cyclophosphamide, Fludarabine, Thiotepa, Mesna Design and Implementation of the Pediatric Liver Transplantation Biobank NCT04477967n/a1 site๐Ÿ“ Chongqing Children's Hospital of Chongqing Medical University ยท Tests: No intervention Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation NCT07256210Phase 21 site๐Ÿ“ Moscow Federal Research Institute of Pediatric Hematology, Oncologโ€ฆ ยท Tests: Donor-derived Natural Killer Cell
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy